To investigate whether M1 to M2a phenotypic conversion of microglia could be accomplished in vivo using cyclic AMP elevation and IL-4 supplementation, their concurrent delivery was investigated after contusive spinal cord injury (SCI) in two different experimental paradigms. The gene discussed is IL4; the disease is spinal cord injury.